EXELIXIS INC EXELIXIS INC EXELIXIS INC

EXELIXIS INC

No trades
See on Supercharts
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.93 B‬EUR
‪188.24 M‬EUR
‪1.66 B‬EUR
‪283.54 M‬
Beta (1Y)
0.58

About Exelixis, Inc.

CEO
Michael M. Morrissey
Headquarters
Alameda
Employees (FY)
‪1.31 K‬
Founded
1994
FIGI
BBG000BL3426
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Curated watchlists where EX9 is featured.

Frequently Asked Questions

The current price of EX9 is 20.31 EUR — it has decreased by 0.05% in the past 24 hours. Watch EXELIXIS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange EXELIXIS INC stocks are traded under the ticker EX9.
EX9 stock has fallen by 3.29% compared to the previous week, the month change is a 1.50% rise, over the last year EXELIXIS INC has showed a 15.63% increase.
We've gathered analysts' opinions on EXELIXIS INC future price: according to them, EX9 price has a max estimate of 29.78 EUR and a min estimate of 15.82 EUR. Watch EX9 chart and read a more detailed EXELIXIS INC stock forecast: see what analysts think of EXELIXIS INC and suggest that you do with its stocks.
EX9 reached its all-time high on Apr 30, 2024 with the price of 22.43 EUR, and its all-time low was 13.60 EUR and was reached on Jul 19, 2021. View more price dynamics on EX9 chart.
See other stocks reaching their highest and lowest prices.
EX9 stock is 0.05% volatile and has beta coefficient of 0.58. Track EXELIXIS INC stock price on the chart and check out the list of the most volatile stocks — is EXELIXIS INC there?
Today EXELIXIS INC has the market capitalization of ‪5.92 B‬, it has increased by 3.22% over the last week.
Yes, you can track EXELIXIS INC financials in yearly and quarterly reports right on TradingView.
No, EX9 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 5, 2024, the company has ‪1.31 K‬ employees. See our rating of the largest employees — is EXELIXIS INC on this list?
Like other stocks, EX9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXELIXIS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXELIXIS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXELIXIS INC stock shows the buy signal. See more of EXELIXIS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.